SOCAR was founded in 1986, and has more than 25 years of experience in the design, conduct, analysis, and reporting of phase I to IV clinical studies. Since our founding, SOCAR has become a leading independent clinical research organization by delivering unparalleled expertise and service to our customers. Today, their clinical expertise, academic, and opinion leader network and operational capabilities enable them to serve their clients worldwide and empower them to safely, efficiently and more quickly commercialize drugs and devices.
|Cardiovascular and related
|Cachexia (chronic heart failure, oncology)
|Cerebrovascular, Central Nervous System
|Haematology (iron deficiency anaemia)
|Metabolic (diabetes, lipidology)
- Scientific Expertise
- Regulatory Affairs
- Project Management
- Data Management
- Endpoint Adjudic.
- Medical Writing
They offer highly responsive, customized pharmacovigilance services which are industry-standard compliant, ranging from small studies to complex, large multinational clinical studies, and registries. Their pharmacovigilance services can be deployed individually or as a package.
SOCAR offers the following pharmacovigilance services:
|Design, development and implementation of the complete Adverse Event database
|Data entry of adverse Events reports for trials using paper CRFs
|Complete e-management of SAE reports for trials using e-CRFs
|Data query resolution and management
|Quality Assurance and Quality Control
|Patient narrative development
|Evaluation of medical integrity and completeness of the reported event
|Coding and validation of coding using MedDRA
|Periodic safety update reports